Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide for Duodenal Antimotility During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Clinical trial NCT00731198 · COMPLETED

Trial details

NCT number: NCT00731198
Sponsor: Changhai Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

ERCP Pancreatic Diseases Bile Duct Diseases

Start date: 2008-08-01
Primary completion: 2009-03-01
Enrollment: 650

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.